Researchers investigated the impact of time to remission, number of flares, and time on immunosuppressives after remission on estimated glomerular filtration rate in patients with lupus nephritis.
Researchers assessed the relationship between interleukin (IL)-6 and IL-17 pathway modulation and clinical outcomes in patients with psoriatic arthritis treated with upadacitinib.
Researchers evaluated health records from a large US health system to determine whether common rheumatologic conditions and immunomodulatory drugs were associated with certain COVID-19 outcomes.
Researchers evaluated the safety and efficacy of upadacitinib in patients with active non-radiographic axial spondyloarthritis.
Researchers evaluated the clinical characteristics, disease burden, and treatment of patients with peripheral spondyloarthritis with and without psoriasis.
Researchers investigated fibronectin (FN1) transcripts associated with osteoarthritis pathophysiology and its effects on FN1 expression modulation.
Study authors noted an increase in time-to-referral for patients with rheumatoid arthritis with autoantibody negativity.
Researchers investigated the choices and sequences of treatment strategies in children with juvenile systemic lupus erythematosus.
Researchers examined meaningful within-patient changes in WOMAC using data from 3 trials that included patients with moderate to severe hip and knee osteoarthritis.
Researchers investigated the risk for infection between leflunomide vs TNFi and tacrolimus vs TFNi among patients with rheumatoid arthritis treated with concomitant methotrexate.
